Dynamic Halbach array magnet integrated microfluidic system for the continuous-flow separation of rare tumor cells
Mei Xue1, An Xiang2, Yanhai Guo2
1Center for Translational Medicine, The First Affiliated Hospital of Xi'an Jiaotong University Xi'an 710061 Shaanxi People's Republic of China.
RSC Advances
|May 11, 2022
Summary
A novel microfluidic system using a moving magnet (dHAMI) effectively isolates rare circulating tumor cells (CTCs) from blood. This method captures white blood cells, allowing pure CTCs for personalized medicine and cancer detection.
Area of Science:
- Biomedical Engineering
- Microfluidics
- Cancer Diagnostics
Background:
- Circulating tumor cells (CTCs) are crucial biomarkers for liquid biopsy and personalized medicine.
- Existing CTC isolation methods face challenges due to CTC rarity and heterogeneity.
- Need for efficient and sensitive methods for isolating intact CTCs from whole blood.
Purpose of the Study:
- To develop and validate a novel microfluidic system for the negative isolation of CTCs.
- To enable continuous-flow separation of CTCs without sample volume limitations.
- To provide intact CTCs for downstream cellular and molecular analyses.
Main Methods:
- Development of a dHAMI (dynamic Halbach array magnet microfluidic system).
- Utilized magnetic beads to label and capture non-target white blood cells (WBCs).
- Employed a continuously moving Halbach array magnet to generate a dynamic magnetic field for WBC exclusion and CTC elution.
- Optimized flow rate and immunomagnetic bead concentration for efficient separation.
Main Results:
- The dHAMI microfluidic system achieved an average CTC capture rate of 91.6% for spiked cells (50-1000 cells/mL).
- Successful isolation of CTCs was completed within 40 minutes.
- CTCs were detected in 100% (10/10) of patient blood samples.
- Demonstrated effective isolation of intact and heterogeneous CTCs.
Conclusions:
- The dHAMI microfluidic system provides an effective platform for isolating intact CTCs.
- The system shows high capture efficiency and robustness for rare cell separation.
- Potential applications include personalized medicine, cancer diagnostics, and separation of other rare cells.


